Derek Jackson

Associate, Washington, D.C.

Derek Jackson

Associate, Washington, D.C.

Derek Jackson is an associate in Cohen & Gresser’s Washington, D.C. office. His practice focuses on disputes in the areas of antitrust, commercial litigation, and white collar defense. Derek has extensive experience advising companies in all aspects of antitrust and competition matters, including private civil litigation and regulatory compliance. He has represented financial institutions against allegations of price-fixing under the Sherman Act and the world’s largest automotive parts supplier in numerous antitrust class action suits. Derek also has experience representing both individuals and corporations in regulatory investigations as well as civil and criminal proceedings in federal and state courts.

Prior to joining the firm, Derek was an associate in the investigations and litigation practice group at Allen & Overy’s Washington, D.C., and New York offices. He served as a judicial intern while in law school for the Chambers of Magistrate Judge Alan Kay of the U.S. District Court for the District of Columbia.

Derek received his J.D. from the University of Virginia School of Law, where he was a Hardy Cross Dillard Scholar and Production Editor of the Journal of Law and Politics.  He received a B.A., magna cum laude, in Philosophy & Government and Politics from the University of Maryland.

Derek Jackson is an associate in Cohen & Gresser’s Washington, D.C. office. His practice focuses on disputes in the areas of antitrust, commercial litigation,…

Education

University of Virginia School of Law (J.D., 2016); University of Maryland (B.A., magna cum laude, 2013)

Bar Admissions

District of Columbia; New York State

Activities and Affiliations

Member, American Bar Association (Young Lawyers Division and Antitrust Law Section)

Twice in the past month, the Federal Trade Commission (FTC) unanimously announced consent decrees that are a strong signal of the current Commission’s intent to investigate private equity transactions aggressively.

  • The consent decrees allow the private equity fund JAB Consumer Partners SCA SICAR's National Veterinary Associates to close two recent deals with some divestitures but also impose a series of strict prior notice requirements that are unprecedented in their breadth.
  • The announcements come a month after the confirmation of a fifth commissioner that gave the Democrats a 3-2 majority on the FTC.
  • As long as Democrats control the majority, private equity firms should be prepared for additional scrutiny and be cognizant of other competition issues that may impact them.
In this client alert, John Roberti, Melissa Maxman, Ronald Wick, David Lisner, and Derek Jackson discuss the potential implications of these rulings for private equity firms and offer insight into how PE firms can be more cognizant of competition and antitrust compliance issues that may pose a potential risk moving forward.